Other and unspecified lesions of oral mucosa
Conditions
Interventions
This is an intervention study (clinical trial), double-blind, prospective, placebo-controlled that will be carried out in the semi-intensive ICU of Hospital de Messejana (HM). The 32 volunteers can be
Sponsors
Hospital de Messejana Dr. Carlos Alberto Studart Gomes
Hospital de Messejana Dr. Carlos Alberto Studart Gomes
Eligibility
Age
30 Years to 65 Years
Inclusion criteria
Inclusion criteria: Individuals (American Society of Anesthesiologists) ASA II and III of both sexes; age between 30 and 65 years; having lesions in the oral cavity; admitted to intensive care units; and with injuries acquired during the hospitalization period
Exclusion criteria
Exclusion criteria: Volunteers with a confirmed history of allergy to tocopherol (Vit. E); pregnant or breastfeeding women; patients whose injury has its origins in the community, prior to hospitalization
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of scar repair. The measurement of the outcome related to the scar repair of the injury will be carried out using a caliper, in which, in the initial consultations, 24h, 72h, 7 days and 14 days, two measurements will be taken: buccolingual (d) and mesiodistal (D ) of the injury, in order to observe the healing process. Such measurements will be made in triplicate, then obtaining an arithmetic average to which the following formula will be applied, in order to obtain the area: (A= p. d. D/4). To measure the contraction of the lesion, the initial area will be subtracted from the other areas (24h, 72h, 7 days and 14 days). | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary stages expected | — |
Countries
Brazil
Contacts
Public ContactIslla Pinheiro
Hospital de Messejana Dr. Carlos Alberto Studart Gomes
Outcome results
None listed